Advanced search×

Antiplatelet Therapy and Coronary Artery Bypass Graft Surgery

Gilles Montalescot, Jean-Sébastien Hulot, and Jean-Philippe Collet

J Am Coll Cardiol 56(24):3 (2010) PMID 21126641

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jacc.2010.05.060
Version: za2963e q8za6 q8zb7 q8zc0 q8zdd q8ze7 q8zf9 q8zge

Similar articles you may find interesting…

  1. President's Page: Employing Shared Decision-Making Models to Improve Care and Patient Value: A Cardiovascular Professional Initiative
    Ralph Brindis and John A Spertus

    J Am Coll Cardiol 56(24):3 (2010) PMID 21126645

  2. Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy
    Marco Pocar, Alessandra Di Mauro, ... Francesco Donatelli

    Eur J Cardiothorac Surg 37(5):8 (2010) PMID 20060737

    Despite advanced cardiomyopathy, SVR determines left ventricular volume reduction and improved systolic function. Baseline absent-to-moderate mitral regurgitation and a more spherical left ventricular geometry predict a less favourable clinical and functional outcome, suggesting a possible rationale...
  3. Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro...
    Dean Papaliodis, William Boucher, ... Theoharis C Theoharides

    J Pharmacol Exp Ther 327(3):665-72 (2008) PMID 18784348

    We show that methylnicotinate induces significant PGD(2) release from human mast cells and serotonin from human platelets. Intradermal injection of methylnicotinate induces rat skin vasodilation and vascular permeability. Niacin increases plasma PGD(2) and serotonin in a rat model of flush. The phen...